These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of hyperlipidemia and immunosuppressive drugs on cardiac allograft vascular disease in heterotopic rat cardiac transplantation. Hisatomi K; Isomura T; Matsuzoe S; Satou T; Hirano A; Kohjiro M Transplant Proc; 1996 Jun; 28(3):1958-60. PubMed ID: 8658960 [No Abstract] [Full Text] [Related]
4. Lipids and lipoproteins alteration after renal transplantation. Mehrsai A; Khajehmougehi A; Afshar K; Emami M; Pourmand G Nephrol Dial Transplant; 1997 Jan; 12(1):233-4. PubMed ID: 9027812 [No Abstract] [Full Text] [Related]
5. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus. Friemann S; Feuring E; Padberg W; Ernst W Transplant Proc; 1998 Jun; 30(4):1240-2. PubMed ID: 9636504 [No Abstract] [Full Text] [Related]
6. No clinical evidence of hyperlipidemia as a risk factor for chronic renal allograft failure. Hillebrand GF; Schlosser S; Schneeberger H; Lorenz B; Zanker B; Samtleben W; Land W Transplant Proc; 1999; 31(1-2):1391-2. PubMed ID: 10083615 [No Abstract] [Full Text] [Related]
7. The effects of lipid-lowering agents on acute renal allograft rejection. Kasiske BL; Heim-Duthoy KL; Singer GG; Watschinger B; Germain MJ; Bastani B Transplantation; 2001 Jul; 72(2):223-7. PubMed ID: 11477342 [TBL] [Abstract][Full Text] [Related]